FY26 Financial Results and Operational Update
Filed with ASX · · 6 pages · English
Summary by 6ix AI
Cogstate Ltd has released its financial results and operational update for the fiscal year, highlighting significant growth in revenue and sales contracts, particularly in the central nervous system clinical trials sector. The company reported record sales contracts and a notable increase in group revenue, alongside strong operating cash flow and a disciplined approach to capital management. Cogstate declared a fully franked annual dividend, reflecting its confidence in long-term growth prospects and cash-generating capabilities. The outlook for the next fiscal year appears strong, with a record contracted revenue and plans for continued investment in technology and operational enhancements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Cogstate
- FY26 Appendix 4E
- Dividend/Distribution - CGS
- FY26 Annual Report
- FY26 App 4G and Corporate Governance Statement
- 2026 Annual General Meeting
Later from Cogstate
- FY26 Results Investor Briefing
- Change in substantial shareholding for CGS
- Application for quotation of securities - CGS
- Notification of cessation of securities - CGS
- 2026 AGM - Access Letter, Notice of Meeting and Sample Proxy
Follow Cogstate into a list and get an email when it puts out news.
Follow Cogstate